The Path to Innovation in Rare Diseases comes through Partnerships – A reflection on the EU Pharmaceutical Package
Rare Disease Day 2023: A Shared Vision for the EU Rare Disease Ecosystem
World Cancer Day 2023: Fostering the EU Advanced Diagnostics Ecosystem to tackle the Cancer Burden
Launch Conditionality: What’s at stake?
From the EUCOPE Blog archives
The increasing importance of Real World Evidence (RWE) and the need for a multi-stakeholder approach
October 27, 2022
What is Needed to Reinforce Biopharmaceutical Innovation in Europe?
October 12, 2022
The European Health Data Space (EHDS): How will it impact health technology companies operating in or about to enter the EU?
September 19, 2022
GUEST: What’s on the horizon for life sciences and health care?
June 30, 2022
Five Priorities for a Successful EU HTA Procedure
April 27, 2022
To the archives
